Literature DB >> 21750517

Viral hepatitis: Ciclosporin versus tacrolimus for HCV transplant recipients.

Marina Berenguer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21750517     DOI： 10.1038/nrgastro.2011.124

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

Review 1.  The immunosuppressive pipeline: meeting unmet needs in liver transplantation.

Authors:  Nazia Selzner; David R Grant; Itay Shalev; Gary A Levy
Journal:  Liver Transpl       Date:  2010-12       Impact factor: 5.799

2.  Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006).

Authors:  Didier Samuel; Xavier Forns; Marina Berenguer; Christian Trautwein; Andrew Burroughs; Mario Rizzetto; Christian Trepo
Journal:  J Hepatol       Date:  2006-05-15       Impact factor: 25.083

3.  Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years.

Authors:  J G O'Grady; P Hardy; A K Burroughs; D Elbourne
Journal:  Am J Transplant       Date:  2006-11-15       Impact factor: 8.086

4.  Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database.

Authors:  W D Irish; S Arcona; D Bowers; J F Trotter
Journal:  Am J Transplant       Date:  2011-05-12       Impact factor: 8.086

5.  Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis.

Authors:  Marina Berenguer; Ana Royuela; Javier Zamora
Journal:  Liver Transpl       Date:  2007-01       Impact factor: 5.799

6.  The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C.

Authors:  M R Foxton; A Quaglia; P Muiesan; M A Heneghan; B Portmann; S Norris; N D Heaton; John G O'Grady
Journal:  Am J Transplant       Date:  2006-08       Impact factor: 8.086

7.  Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.

Authors:  Marina Berenguer; Victoria Aguilera; Fernando San Juan; Salvador Benlloch; Angel Rubin; Rafael López-Andujar; Angel Moya; Eugenia Pareja; Eva Montalva; Maria Yago; Manuel de Juan; José Mir; Martín Prieto
Journal:  Transplantation       Date:  2010-12-15       Impact factor: 4.939

Review 8.  Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.

Authors:  Marina Berenguer
Journal:  J Hepatol       Date:  2008-05-22       Impact factor: 25.083

9.  Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation.

Authors:  Gary Levy; Federico Villamil; Didier Samuel; Fernando Sanjuan; Gian Luca Grazi; You Wu; Paul Marotta; Oliver Boillot; Ferdinand Muehlbacher; Goran Klintmalm
Journal:  Transplantation       Date:  2004-06-15       Impact factor: 4.939

Review 10.  The role of immunosuppression in recurrence of hepatitis C.

Authors:  John R Lake
Journal:  Liver Transpl       Date:  2003-11       Impact factor: 5.799
  10 in total
  1 in total

Review 1.  Virus-drug interactions--molecular insight into immunosuppression and HCV.

Authors:  Qiuwei Pan; Hugo W Tilanus; Herold J Metselaar; Harry L A Janssen; Luc J W van der Laan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.